Review Article: Precision Oncology Tumor Board
Precision medicine: BRAF mutations in thyroid cancer
Precision Cancer Medicine
2019;
2:
29
(22 November 2019)
Review Article: Precision Oncology Tumor Board
Cancer diagnosis after solid organ transplantation: do we need to know the cell of origin?
Precision Cancer Medicine
2019;
2:
28
(22 November 2019)
Review Article: Precision Oncology Tumor Board
Targeting ErbB2 aberrations in non-small cell lung cancer
Precision Cancer Medicine
2019;
2:
27
(22 November 2019)
Review Article
Robotic thoracic surgery, the age of majority
Precision Cancer Medicine
2019;
2:
26
(02 September 2019)
Review Article
Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer
Precision Cancer Medicine
2019;
2:
25
(22 August 2019)
Review Article
Low-dose lung cancer screening: nodule measurement and management
Precision Cancer Medicine
2019;
2:
24
(12 August 2019)
Editorial
Precision Oncology Tumor Board—a new series to facilitate a global dialogue
Precision Cancer Medicine
2019;
2:
23
(29 July 2019)
Editorial
People change through adaptation and because of urgency
Precision Cancer Medicine
2019;
2:
22
(02 July 2019)
Review Article
The role of immunotherapy in mesothelioma
Precision Cancer Medicine
2019;
2:
21
(13 June 2019)
Review Article
Training and precision surgery in VATS lobectomy
Precision Cancer Medicine
2019;
2:
20
(11 June 2019)
Review Article
Implementation of functional precision medicine for anaplastic lymphoma kinase-rearranged non-small lung cancer
Precision Cancer Medicine
2019;
2:
19
(11 June 2019)
Review Article
Role and room for biomarkers in non-small cell lung cancer
Precision Cancer Medicine
2019;
2:
18
(06 June 2019)
Review Article
Pathology in non-small cell lung cancer: evolving scenario
Precision Cancer Medicine
2019;
2:
17
(05 June 2019)
Review Article
ALK disease: best first or later, and do we care about variants?
Precision Cancer Medicine
2019;
2:
16
(27 May 2019)
Review Article
Custom-made prosthesis in thoracic surgery
Precision Cancer Medicine
2019;
2:
15
(15 May 2019)
Review Article
How to improve the precision of closed chest sublobar resections
Precision Cancer Medicine
2019;
2:
14
(19 April 2019)
Review Article
Disease progression in non-small cell lung cancer on immune-checkpoint inhibition, what are the options?
Precision Cancer Medicine
2019;
2:
13
(12 April 2019)
Editorial Commentary
Hanging in the balance: mitochondrial uncoupling protein-2 and the tumor microenvironment
Precision Cancer Medicine
2019;
2:
12
(08 April 2019)
Review Article
Planning and marking small nodules for surgery
Precision Cancer Medicine
2019;
2:
11
(28 March 2019)
Review Article
Prophylactic cranial irradiation (PCI) or magnetic resonance imaging (MRI) monitoring in limited small cell lung cancer: is it a question?
Precision Cancer Medicine
2019;
2:
10
(28 March 2019)
Review Article
Patient-tailored prevention of post-operative complications after lung resection
Precision Cancer Medicine
2019;
2:
9
(27 March 2019)
Review Article
Alternative non-homologous end joining repair: a master regulator of genomic instability in cancer
Precision Cancer Medicine
2019;
2:
8
(08 March 2019)
Editorial
Access to the medicine market—we could do better!
Precision Cancer Medicine
2019;
2:
7
(05 March 2019)
Editorial
Clinical outcomes provide new insights into transformation to small-cell lung cancer of pulmonary EGFR-mutant adenocarcinoma
Precision Cancer Medicine
2019;
2:
5
(04 March 2019)
Editorial
Long non-coding RNA MALAT1 as metastasis suppressor
Precision Cancer Medicine
2019;
2:
4
(22 February 2019)
Editorial
Radiomic features of the lung: a promising marker to predict response to immune-checkpoint inhibitors in non-small lung cancer patients
Precision Cancer Medicine
2019;
2:
3
(14 February 2019)
Mini-Review
Guanine residues of precursor microRNA’s terminal loop as a potential target for cancer therapy and prevention
Precision Cancer Medicine
2019;
2:
2
(13 February 2019)
Editorial
4-1BB-mediated cancer immunotherapy: ‘mission impossible’ for non-engineered IgGs?
Precision Cancer Medicine
2019;
2:
1
(18 January 2019)
Editorial
Liquid biopsy for tumor mutational burden predicts the effectiveness of atezolizumab in non-small cell lung cancer treatment
Precision Cancer Medicine
2018;
1:
21
(28 November 2018)
Meet the Professor
Prof. Stephen M. Hahn: the important role of radiation oncology in precision oncology
Precision Cancer Medicine
2018;
1:
20
(23 November 2018)
Editorial
Liquid biopsy-based biomarkers for early detection of pancreatic cancer
Precision Cancer Medicine
2018;
1:
19
(30 October 2018)
Editorial
A step forward in the management of a rare disease, the anaplastic lymphoma kinase-rearranged non-small cell lung cancer
Precision Cancer Medicine
2018;
1:
18
(12 October 2018)
Meet the Professor
Philippe Lambin: how advances in imaging impact precision radiation oncology?
Precision Cancer Medicine
2018;
1:
17
(30 September 2018)
Mini-Review
What is the best drug as a front-line treatment for EGFR activating mutation?
Precision Cancer Medicine
2018;
1:
16
(30 September 2018)
Meet the Professor
Bhadrasain Vikram: future road of radiation—radiomics and genomics will play important roles
Precision Cancer Medicine
2018;
1:
15
(25 September 2018)
Editorial
PLX51107, a promising novel bromodomain and extra-terminal inhibitor in chronic lymphoid leukemia treatment
Precision Cancer Medicine
2018;
1:
14
(20 September 2018)
Editorial
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Precision Cancer Medicine
2018;
1:
13
(18 September 2018)
Editorial
Fatty acids: from adipocytes to cancer cells
Precision Cancer Medicine
2018;
1:
12
(14 September 2018)
Meet the Professor
Dr. Shankar Siva: combination of immunotherapy and stereotactic ablative radiotherapy may be a better choice for cancer patients
Precision Cancer Medicine
2018;
1:
11
(04 September 2018)
Meet the Professor
Dr. Michael Milano: a better understanding in how radiation interacts with immunotherapy will be a future trend of precision cancer research
Precision Cancer Medicine
2018;
1:
10
(24 August 2018)
Meet the Professor
Ben Slotman: bringing advances in radiation oncology to the clinic is fulfilling
Precision Cancer Medicine
2018;
1:
9
(23 August 2018)
Perspective
Personalized medicine—but this time for real!
Precision Cancer Medicine
2018;
1:
8
(03 August 2018)
Review Article
The structure of mTOR complexes at a glance
Precision Cancer Medicine
2018;
1:
7
(03 August 2018)
Meet the Professor
Prof. Ramon Rami Porta: the internationalization of IASLC database should entail the contribution of data from China
Precision Cancer Medicine
2018;
1:
6
(17 July 2018)
Original Article
Direct comparison of autofluorescence bronchoscopy (AFB) and the combination of autofluorescence bronchoscopy and white light bronchoscopy (AFB + WLB) for detecting airway cancerous and precancerous lesions: a systematic review and meta-analysis
Precision Cancer Medicine
2018;
1:
5
(13 July 2018)
Editorial
Diffuse large B-cell lymphoma with molecular variations more than ABC and GCB classification
Precision Cancer Medicine
2018;
1:
4
(06 July 2018)
Case Report
Rociletinib-related bilateral cataract
Precision Cancer Medicine
2018;
1:
3
(14 June 2018)
Meet the Professor
Xiaomao Guo: help cancer patients with precision medicine
Precision Cancer Medicine
2018;
1:
2
(14 June 2018)
Foreword
Precision cancer medicine: deliver a lasting blow to cancer!
Precision Cancer Medicine
2018;
1:
1
(16 April 2018)